Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E.J. Wilkinson, B. Kneale, P.J. Lynch.
Report of the ISSVD Terminology Committee.
J Reprod Med, 31 (1986), pp. 973-974
[2.]
E.J. Wilkinson.
The 1989 Presidential Address International Society for the Study of Vulvar Disease.
J Reprod Med, 35 (1990), pp. 981-991
[3.]
U. Beller, M. Sideri, P. Maisonneuve, J.L. Benedet, A.P.M. Heintz, H.Y.S. Ngan, et al.
Carcinoma of the vulva. FIGO Annual Report on the Results of Treatment in Gynaecological Cancer. 24th volume.
J Epidemiol Biostat, 6 (2001), pp. 153-174
[4.]
J.D. Woodruff, C. Julian, T. Puray, S. Mermut, P. Katayama.
The contemporary challenge of carcinoma in situ of the vulva.
Am J Obstet Gynecol, 115 (1973), pp. 677-686
[5.]
E.G. Friedrich, E.J. Wilkinson, Y.S. Fu.
Carcinoma in situ of the vulva: a continuing challenge.
Am J Obstet Gynecol, 136 (1980), pp. 830-843
[6.]
H. Japaze, R. García-Buñuel, J.D. Woodruff.
Primary vulvar neoplasia. A review of in situ and invasive carcinoma, 1935-1972.
Obstet Gynecol, 49 (1977), pp. 404-411
[7.]
B. Andreasson, J. Bock.
Intraepithelial neoplasia in the vulvar region.
Gynecol Oncol, 21 (1985), pp. 300-305
[8.]
S.R. Sturgeon, L.A. Brinton, S.S. Devesa, R.J. Kurman.
In situ and invasive vulvar cancer incidence trends (1973 to 1987).
Am J Obstet Gynecol, 66 (1992), pp. 1482-1485
[9.]
W.T. Creasman, J.L. Phillips, H.R. Menck.
The national cancer data base report on early stage invasive vulvar carcinoma.
Cancer, 80 (1997), pp. 505-513
[10.]
Annual Report on the results of treatment in gynecological cancer, n.° 19, Radiumhemmet, (1985),
[11.]
Annual Report on the results of treatment in gynecological cancer, n.° 20, Radiumhemmet, (1988),
[12.]
Annual Report on the results of treatment in gynecological cancer, n.° 21. Stockholm: Radiumhemmet 1991.
Int J Gynecol Obstet, 36 (1991), pp. 1-315
[13.]
Annual Report on the results of treatment in gynecological cancer, n.° 22, Radiumhemmet, (1994),
[14.]
Annual Report on the results of treatment in gynecological cancer, n.° 23.
J Epidemiol Biostat, 3 (1998), pp. 1
[15.]
Annual Report on the results of treatment in gynecological cancer, n.° 24.
J Epidemiol Biostat, 6 (2001), pp. 153-174
[16.]
J. González-Merlo, L.M. Puig-Tintoré.
Cáncer de vulva (estudio cooperativo nacional: resumen y conclusiones).
pp. 327-345
[17.]
L.M. Puig-Tintoré, et al.
Neoplasia vulvar intraepitelial.
Ginecología oncológica, 2.a ed, pp. 25-39
[18.]
L.M. Puig-Tintoré.
Lesiones preinvasoras de la vulva (VIN). Concepto, clínica y diagnóstico.
Acta Ginecol, 58 (2001), pp. 190-195
[19.]
R.W. Jones, J. Baranyai, S. Stables.
Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia.
Obstet Gynecol, 90 (1997), pp. 448-452
[20.]
E.A. Joura, A. Losch, M.G. Haider-Angeler, G. Breitenecker, S. Leodolter.
Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women.
J Reprod Med, 45 (2000), pp. 613-615
[21.]
R.J. Kurman, H.J. Norris, E. Wilkinson.
Tumors of the cervix, vagina, and vulva.
Armed forces institute of pathology. Bethesda, (1992), pp. 183-191
[22.]
M.S. Baggish, J. Dorsey.
CO2 laser for the treatment of vulvar carcinoma in situ.
Obstet Gynecol, 57 (1981), pp. 371-375
[23.]
P. Shatz, C. Bergeron, E.J. Wilkinson, J. Arseneau, A. Ferenczy.
Vulvar intraepithelial neoplasia and skin appendage involvement.
Obstet Gynecol, 74 (1989), pp. 769-774
[24.]
M.J. Messing, D.G. Gallup.
Carcinoma of the vulva in young women.
Obsteg Gynecol, 86 (1995), pp. 51-54
[25.]
J. Carter, J. Carlson, J. Fowler, E. Hartenbach, L. Adcock, L. Carson, et al.
Invasive vulvar tumors in young women.
A disease of the immunosupressed? Gynecol Oncol, 51 (1993), pp. 307-310
[26.]
C.L. Trimble, A. Hildesheim, L.A. Brinton, K.V. Shah, R.J. Kurman.
Heterogeneous etiology of squamous carcinoma of the vulva.
Obstet Gynecol, 87 (1996), pp. 59-64
[27.]
Y. Sun, A. Hildesheim, L.A. Brinton, P.C. Nasca, C.L. Trimble, R.J. Kurman, et al.
Human papillomavirus-specific serologic response in vulvar neoplasia.
Gynecol Oncol, 63 (1996), pp. 200-203
[28.]
U. Hording, S. Daugaard, J. Junge, F. Lundvall.
Human papillomavirus and multifocal genital neoplasia.
Int J Gynecol Pathol, 15 (1996), pp. 230-234
[29.]
M.M. Madeleine, J.R. Daling, J.J. Carter, G.C. Wipf, S.M. Schwartz, B. McKnight, et al.
Cofactors with human papillomavirus in a population-based study of vulvar cancer.
J Natl Cancer Inst, 89 (1997), pp. 1516-1523
[30.]
A. Hildesheim, C.L. Han, L.A. Brinton, R.J. Kurman, J.T. Schiller.
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological casecontrol study.
Obstet Gynecol, 90 (1997), pp. 748-754
[31.]
M. Spitzer.
Lower genital tract intraepithelial neoplasia in HIVinfected women: guidelines for evaluation and management.
Obstet Gynecol Surv, 54 (1999), pp. 131-137
[32.]
B. Volgger, C. Marth, A. Zeimet, E. Muller-Holzner, N. Ruth, O. Dapunt.
Fulminant course of a microinvasive vulvar carcinoma in an immunosuppresed woman.
Gynecol Oncol, 65 (1997), pp. 177-179
[33.]
P.D. Abercrombie, A.P. Korn.
Vulvar intraepithelial neoplasia in women with HIV.
AIDS Patient Care STDS, 12 (1998), pp. 251-254
[34.]
C.G. Collins, J.J. Román-López, F.Y.L. Lee.
Intraepithelial carcinoma of the vulva.
Am J Obstet Gynecol, 108 (1970), pp. 1187-1191
[35.]
J.G. Boutselis.
Intraepithelial carcinoma of the vulva.
Am J Obstet Gynecol, 113 (1972), pp. 733-738
[36.]
J.D. Woodruff, C. Julian, T. Puray, S. Mermut, P. Katayama.
The contemporary challenge of carcinoma in situ of the vulva.
Am J Obstet Gynecol, 115 (1973), pp. 677-686
[37.]
J.P. Forney, C.P. Morrow, D.E. Townsend, P. DiSaia.
Management of carcinoma in situ of the vulva.
Am J Obstet Gynecol, 127 (1977), pp. 801-806
[38.]
J. Buscema, J.D. Woodruff, T.H. Parmley, R. Genadry.
Carcinoma in situ of the vulva.
Obstet Gynecol, 55 (1980), pp. 225-230
[39.]
E.G. Friedrich, E.J. Wilkinson, Y.S. Fu.
Carcinoma in situ of the vulva: a continuing challenge.
Am J Obstet Gynecol, 136 (1980), pp. 830-843
[40.]
M.A. Rettenmaier, M.L. Berman, P.J. DiSaia.
Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia.
Obstet Gynecol, 69 (1987), pp. 247-250
[41.]
W. Chafe, A. Richards, L. Morgan, E. Wilkinson.
Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN).
Gynecol Oncol, 31 (1988), pp. 154-162
[42.]
J.J. Herod, M.I. Shafi, T.P. Rollason, J.A. Jordan, D.M. Luesley.
Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva.
Br J Obstet Gynaecol, 103 (1996), pp. 453-546
[43.]
S.C. Modesitt, A.B. Waters, L. Walton, J.r. Fowler WC, L. Van Le.
Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence.
Obstet Gynecol, 92 (1998), pp. 962-966
[44.]
N. Husseinzadeh, C. Recinto.
Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN 3).
Gynecol Oncol, 73 (1999), pp. 119-120
[45.]
Puig-Tintoré LM, Ordi J, Vidal-Sicart S, Lejárcegui JA, Torné A, Pahisa J, Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol [aceptado para publicación]
[46.]
L.M. Puig-Tintoré, P. Jou Collell, L. Casanova Domenech, J.A. Lejarcegui Fort, B. Guix Melcior, et al.
Neoplasia intraepitelial y cáncer de la vulva.
Oncología ginecológica, pp. 1-60
[47.]
C. De Belilovsky, M. Lessana-Leibowitch.
Bowen's disease and bowenoid papulosis: comparative clinical, viral, and disease progression aspects.
Contracept Fertil Sex, 21 (1993), pp. 231-236
[48.]
R.W. Jones, D.M. Rowan.
Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma.
Obstet Gynecol, 84 (1994), pp. 741-745
[49.]
J.J. Herod, M.I. Shafi, T.P. Rollason, J.A. Jordan, D.M. Luesley.
Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women.
Br J Obstet Gynaecol, 103 (1996), pp. 446-452
[50.]
M.J. Kagie.
Aspects of malignant progression of vulvar epithelial disorders.
Eur J Obstet Gynecol Rep Biol, 80 (1998), pp. 1-3
[51.]
R.W. Jones, D.M. Rowan.
Spontaneous regression of vulvar intraepithelial neoplasia 2-3.
Obstet Gyneco, 96 (2000), pp. 470-472
[52.]
J.P. Forney, C.P. Morrow, D.E. Townsend, P. DiSaia.
Management of carcinoma in situ of the vulva.
Am J Obstet Gynecol, 127 (1977), pp. 801-806
[53.]
F. Rutledge, M. Sinclair.
Treatment of intraepithelial carcinoma of the vulva by skin excision and graft.
Am J Obstet Gynecol, 102 (1968), pp. 806-818
[54.]
P.J. DiSaia, W.M. Rich.
Surgical approach to multifocal carcinoma in situ of the vulva.
Am J Obstet Gynecol, 140 (1981), pp. 136-145
[55.]
L. Mir y Mir.
Plastias locales (plastias de vecindad).
Conceptos y técnicas generales en cirugía plástica, pp. 131-231
[56.]
A. Ayhan, Z.S. Tuncer, L. Dogan, K. Yuce, T. Kucukali.
Skinning vulvectomy for the treatment of vulvar intraepithelial neoplasia 2-3: a study of 21 cases.
Eur J Gynaecol Oncol, 19 (1998), pp. 508-510
[57.]
R.H. Kaufman.
Intraepithelial neoplasia of the vulva.
Gynecol Oncol, 84 (1995), pp. 741-745
[58.]
J. Bornstein, R.H. Kaufman.
Combination of surgical excision and carbon dioxide laser vaporization for multifocal vulvar intraepithelial neoplasia.
Am J Obstet Gynecol, 158 (1988), pp. 459-464
[59.]
M.I. Shafi, D.M. Luesley, P. Byrne, J.S. Sambra, C.W. Redman, J.A. Jordan, et al.
Vulval intraepithelial neoplasia-management and outcome.
Brit J Obstet Gynaecol, 96 (1989), pp. 1339-1444
[60.]
U.R. Hengge, R. Stark.
Topical imiquimod to treat intraepidermal carcinoma.
Arch Dermatol, 137 (2001), pp. 709-711
[61.]
A. Mackenzie-Wood, S. Kossard, J. De Launey, B. Wilkinson, M.L. Owens.
Imiquimod 5% cream in the treatment of Bowen's disease.
J Am Acad Dermtol, 44 (2001), pp. 462-470
[62.]
K.J. Smith, M. Germain, H. Skelton.
Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Dermatol Surg, 27 (2001), pp. 561-564
[63.]
K.J. Smith, M. Germain, H. Skelton.
Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimol 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy.
Dermatol Surg, 27 (2001), pp. 143-146
[64.]
R. Marks, K. Gebauer, S. Shumack, M. Amies, J. Bryden, T.L. Fox, et al.
The Australasian Multicentre Trial Group. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
J Am Acad Dermatol, 44 (2001), pp. 807-813
[65.]
G. Davis, J. Wentworth, J. Richard.
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
J Reprod Med, 45 (2000), pp. 619-623
[66.]
B. Wigbels, T. Luger, D. Metze.
Imiquimod: a new treatment possibility in bowenoid papulosis?.
Hautarzt, 52 (2001), pp. 128-131
[67.]
C. Diaz-Arrastia, I. Arany, S.C. Robazetti, T.V. Dinh, Z. Gatalica, S.K. Tyring, et al.
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical iiquimod 5%.
Clin Cancer Res, 7 (2001), pp. 3031-3033
[68.]
R.W. Todd, I.J. Etherington, D.M. Luesley.
The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia.
Gynecol Oncol, 85 (2002), pp. 67-70
[69.]
E.S. Abdel-Hady, P. Martin-Hirsch, M. Duggan-Keen, P.L. Stern, J.V. Moore, G. Corbitt, et al.
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
Cancer Res, 61 (2001), pp. 192-196
[70.]
P.L. Martin-Hirsch, C. Whitehurst, C.H. Buckley, J.V. Moore, H.C. Kitchener.
Photodynamic treatment for lower genital tract intraepithelial neoplasia.
Lancet, 351 (1998), pp. 1403
[71.]
P. Hillemanns, M. Untch, C. Dannecker, R. Baumgartner, H. Stepp, J. Diebold, et al.
Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid.
Int J Cancer, 85 (2000), pp. 649-653
[72.]
M.K. Fehr, R. Hornung, V.A. Schwarz, R. Simeon, U. Haller, P. Wyss.
Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid.
Gynecol Oncol, 80 (2001), pp. 62-66
[73.]
H.A. Kurwa, R.J. Barlow, S. Neill.
Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy.
Br J Dermatol, 143 (2000), pp. 1040-1042
[74.]
T.E. Carson, W.J. Hoskins, J.F. Wurzel.
Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva.
Obstet Gynecol, 47 (1976), pp. S59-S62
[75.]
F.H. Sillman, A. Sedlis, J.G. Boyce.
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Obstet Gynecol Surv, 40 (1985), pp. 190-220
[76.]
G. De Palo, B. Stefanon, F. Rilke, S. Pilotti, M. Ghione.
Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with viral cytopathic effects. A pilot study.
J Reprod Med, 30 (1985), pp. 404-408
[77.]
C. Vilmer, S. Havard, B. Cavelier-Balloy, M. Pelisse, L. Dubertret, M. Leibowitch.
Failure of isotretinoin and interferon-alpha combination therapy for VPH-linked severe vulvar dysplasia. A report of two cases.
J Reprod Med, 43 (1998), pp. 693-695
[78.]
G. Orlando, M.M. Fasolo, R. Beretta, S. Merli, A. Cargnel.
Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients.
Aids, 16 (2002), pp. 447-450
[79.]
S. Koonsaeng, C. Verschraegen, R. Freedman, M. Bossens, A. Kudelka, J. Kavanagh, et al.
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
J Med Virol, 64 (2001), pp. 195-198
[80.]
J.S. Rader, J.F. Leake, M.B. Dillon, N.B. Rosenheim.
Ultrasonic surgical aspiration in thre treatment of vulvar disease.
Obstet Gynecol, 77 (1991), pp. 573-576
Copyright © 2002. Sociedad Española de Ginecología y Obstetricia